Edition:
United States

Silence Therapeutics PLC (SLN.L)

SLN.L on London Stock Exchange

197.00GBp
13 Dec 2017
Change (% chg)

-4.50 (-2.23%)
Prev Close
201.50
Open
200.00
Day's High
200.00
Day's Low
197.00
Volume
33,461
Avg. Vol
293,830
52-wk High
254.75
52-wk Low
71.88

Chart for

About

Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a... (more)
No analyst recommendations are available for .

Overall

Beta: 0.99
Market Cap(Mil.): £141.03
Shares Outstanding(Mil.): 69.99
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 188.50 15.25
EPS (TTM): -- -- --
ROI: -- -11.67 33.27
ROE: -- -36.21 16.35

BRIEF-Silence Therapeutics Says Sold Further Part Of Holding In Arrowhead Pharmaceuticals Inc

* HAS SOLD A FURTHER PART OF ITS HOLDING OF COMMON SHARES IN ARROWHEAD PHARMACEUTICALS INC.

Dec 11 2017

BRIEF-Silence Therapeutics Says Sold Part Of Holding Of Common Shares In Arrowhead Pharmaceuticals

* THAT IT HAS SOLD PART OF ITS HOLDING OF COMMON SHARES IN ARROWHEAD PHARMACEUTICALS INC​

Dec 04 2017

BRIEF-Silence Therapeutics Plc Reports 6.4 Pct Stake In Arrowhead Pharmaceuticals As Of Nov 29

* SILENCE THERAPEUTICS PLC REPORTS 6.4 PERCENT STAKE IN ARROWHEAD PHARMACEUTICALS INC AS OF NOVEMBER 29 - SEC FILING

Dec 01 2017

BRIEF-Silence Therapeutics licensee Quark announces positive AKI results

* NOTES QUARK PHARMACEUTICAL PRESS RELEASE WHICH REPORTS POSITIVE RESULTS FROM PHASE 2 STUDY

Jul 27 2017

BRIEF-Silence Therapeutics says ‍CEO Ali Mortazavi appointed non-executive chairman of Ultromics

* Says ‍CEO Ali Mortazavi has been appointed as non-executive chairman of Ultromics with immediate effect​ Source text: http://bit.ly/2tPOoWz Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Jul 14 2017

Earnings vs. Estimates